Tag: VED Drugs

WHO Updated Lists of Essential Medicines and Diagnostics

who
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable thro...

Kyrgyzstan approved its new List of Vital and Essential Drugs

pharmacy
The government of the Kyrgyz Republic has approved national lists of vital and essential drugs and medical devices. A corresponding decision was signed by Prime Minister of the Kyrgyz Republic Mukhammedkalyi Abylgaziev.

Moscow Endocrine Plant can become a leader of the Russian pharma industry

moscow endocrine plant
In May 2018, the Moscow Endocrine Plant celebrated its 75th anniversary. Today, the enterprise has a strong position in the Russian pharmaceutical market and manufactures a wide range of socially important medicines.

Russian drugs are increasing their share in oncology and hepatitis market segments

manufacturing
In 2017, the share of Russian medicines for the treatment of oncological diseases reached almost 50% in this market segment. This is confirmed by the report of the Russian Ministry of Industry and Trade for 2017.

Russian Ministry of Health proposes to introduce fines for inflating prices of VED

blisters
Sanctions will be imposed on pharmacists and drug manufacturers inflating prices of vital and essential drugs (VED). The Ministry of Health proposed to introduce fines for inflating prices of VED.

Moscow plans to further develop offset agreement mechanism

drug development
Offset agreements are a new effective mechanism for public procurement, in which the supplier agrees to establish or upgrade a production facility within the city, while the city authorities agree to purchase the products.

Pharmaceutical manufacturers may be fined 5 million rubles for false information

pharma manufacturing
For incomplete or distorted provision of details, which caused harm to the life or health of citizens, the draft law establishes the administrative liability in the form of a fine ranging from one million to five million rubles.

Share of Russian HIV and cancer drugs increased significantly

manufacturing
The share of Russian-made medicines in the List of Vital and Essential Drugs increased by 10% in monetary terms over the five past years. This was announced by the Deputy Minister of Industry and Trade of the Russian Federation.

70 import-substituting Russian medicines were launched onto the market

drug-manufacturing
The production of high-quality, domestically manufactured drugs in the key segments allows to make significant savings of budgetary funds and reduces the dependence of Russian health care system on the imports of medicines

Importers to Russia saved 2.66 billion rubles on customs duties and VAT

medicines
In January - November 2017, 86.3% of all supplies of finished dosage forms included in the list of vital and essential drugs were imported to Russia at the prices below those established in the State Register

ZiO-Zdorovie launched the manufacturing of vital and essential drugs

zio-zdorovje
The Governor of the Moscow region Andrey Vorobyov and Alexey Gordeyev, the Presidential Plenipotentiary Envoy to the Central Federal District, launched the second production line at the pharmaceutical plant of ZiO-Zdorovie

First phase of Besins Healthcare plant construction is completed in Yaroslavl

Besins Healthcare
The plant will carry out the full-cycle production of Utrogestan, a unique hormonal drug for women. The medicine is included in the Russian list of vital and essential drugs.

Share of Russian medicines in VED List has reached 84%

drug manufacturing
The share of domestically manufactured vital and essential drugs available on the Russian market has reached 84%, said the Russian Minister of Industry and Trade Denis Manturov

Prices for medicines from VED List declined in Russia by 1.8% over the year

rusdrugs
According to the officials of the Russian Ministry of Health, the medicines from VED List become less expensive as a result of government regulation and price monitoring in this category

About 0.5 trillion rubles are allocated for procurement of VED drugs in Russia

medvedev
Notwithstanding the market economy, the state must constantly monitor the prices of medicines, because this issue concerns everyone who lives in Russia

83.6 percent of medicines from VED List are being manufactured in Russia

alexey alekhin
This was announced by the Director of the Pharmaceutical and Medical Industry Development Department of the Russian Ministry of Industry and Trade